Role of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats

A. M. Myint, S. O'Mahony, M. Kubera, Yong Ku Kim, C. Kenny, A. Kaim-Basta, H. W.M. Steinbusch, B. E. Leonard

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Treatment with pro-inflammatory cytokine, IFNα was documented to result in neuropsychiatric complications including depression and treatment with antidepressant, paroxetine could improve the depressive symptoms. Therefore, the effects of IFNα on behaviour and cytokine changes in the whole blood culture and in the prefrontal cortex, hypothalamus and hippocampus areas of the brain in wistar rats were investigated with emphasis on the role of paroxetine in the prevention of depressive behaviour induced by pro-inflammatory cytokines. The group of rats treated with IFNα (S.C. 50 000 IU/kg for 3 days/week for 5 weeks) was compared with three other groups; 1) saline control group (S.C. normal saline 0.2 ml/kg/day for 7 weeks), 2) paroxetine control group (paroxetine suspension orally 10 mg/kg/day for 7 weeks) and 3) group treated with paroxetine for 2 weeks followed by IFNα for 5 weeks. In open filed, the IFNα treated rats showed anxiety behaviour compared to the rats from the other groups. There was no significant difference in home cage emergence test, Morris water maze and object recognition test. There is no significant difference in plasma corticosterone between groups. The pro-inflammatory cytokines (TNFα, IL1β and IFNγ), were significantly higher whereas the anti-inflammatory cytokine, IL10 was lower in the stimulated whole blood culture of IFNα treated rats. In the brain, both pro-inflammatory cytokine IL1β and anti-inflammatory cytokine IL10 were higher in hypothalamus of the IFNα treated rats; by contrast the concentration of IL10 was lowest in hippocampus region of this group compared to the other groups. The paroxetine pretreated rats did not show these cytokine changes following IFNα treatment. Thus it appears that paroxetine pretreatment prevents the pro-inflammatory changes in blood and brain following IFNα treatment in turn prevents the anxiety behaviour.

Original languageEnglish
Pages (from-to)843-850
Number of pages8
JournalJournal of Psychopharmacology
Volume21
Issue number8
DOIs
Publication statusPublished - 2007 Nov 1

Fingerprint

Paroxetine
Interferon-gamma
Wistar Rats
Cytokines
Interleukin-10
Hypothalamus
Hippocampus
Brain
Anti-Inflammatory Agents
Anxiety
Depression
Control Groups
Corticosterone
Prefrontal Cortex
Antidepressive Agents
Suspensions
Water

Keywords

  • Anxiety
  • Depression
  • IL-10
  • Interferon-α
  • Proinflammatory cytokine

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Role of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats. / Myint, A. M.; O'Mahony, S.; Kubera, M.; Kim, Yong Ku; Kenny, C.; Kaim-Basta, A.; Steinbusch, H. W.M.; Leonard, B. E.

In: Journal of Psychopharmacology, Vol. 21, No. 8, 01.11.2007, p. 843-850.

Research output: Contribution to journalArticle

Myint, AM, O'Mahony, S, Kubera, M, Kim, YK, Kenny, C, Kaim-Basta, A, Steinbusch, HWM & Leonard, BE 2007, 'Role of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats', Journal of Psychopharmacology, vol. 21, no. 8, pp. 843-850. https://doi.org/10.1177/0269881107077165
Myint, A. M. ; O'Mahony, S. ; Kubera, M. ; Kim, Yong Ku ; Kenny, C. ; Kaim-Basta, A. ; Steinbusch, H. W.M. ; Leonard, B. E. / Role of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats. In: Journal of Psychopharmacology. 2007 ; Vol. 21, No. 8. pp. 843-850.
@article{2c9190f2efc048249a14922eb34af791,
title = "Role of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats",
abstract = "Treatment with pro-inflammatory cytokine, IFNα was documented to result in neuropsychiatric complications including depression and treatment with antidepressant, paroxetine could improve the depressive symptoms. Therefore, the effects of IFNα on behaviour and cytokine changes in the whole blood culture and in the prefrontal cortex, hypothalamus and hippocampus areas of the brain in wistar rats were investigated with emphasis on the role of paroxetine in the prevention of depressive behaviour induced by pro-inflammatory cytokines. The group of rats treated with IFNα (S.C. 50 000 IU/kg for 3 days/week for 5 weeks) was compared with three other groups; 1) saline control group (S.C. normal saline 0.2 ml/kg/day for 7 weeks), 2) paroxetine control group (paroxetine suspension orally 10 mg/kg/day for 7 weeks) and 3) group treated with paroxetine for 2 weeks followed by IFNα for 5 weeks. In open filed, the IFNα treated rats showed anxiety behaviour compared to the rats from the other groups. There was no significant difference in home cage emergence test, Morris water maze and object recognition test. There is no significant difference in plasma corticosterone between groups. The pro-inflammatory cytokines (TNFα, IL1β and IFNγ), were significantly higher whereas the anti-inflammatory cytokine, IL10 was lower in the stimulated whole blood culture of IFNα treated rats. In the brain, both pro-inflammatory cytokine IL1β and anti-inflammatory cytokine IL10 were higher in hypothalamus of the IFNα treated rats; by contrast the concentration of IL10 was lowest in hippocampus region of this group compared to the other groups. The paroxetine pretreated rats did not show these cytokine changes following IFNα treatment. Thus it appears that paroxetine pretreatment prevents the pro-inflammatory changes in blood and brain following IFNα treatment in turn prevents the anxiety behaviour.",
keywords = "Anxiety, Depression, IL-10, Interferon-α, Proinflammatory cytokine",
author = "Myint, {A. M.} and S. O'Mahony and M. Kubera and Kim, {Yong Ku} and C. Kenny and A. Kaim-Basta and Steinbusch, {H. W.M.} and Leonard, {B. E.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1177/0269881107077165",
language = "English",
volume = "21",
pages = "843--850",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications Ltd",
number = "8",

}

TY - JOUR

T1 - Role of paroxetine in interferon-α-induced immune and behavioural changes in male Wistar rats

AU - Myint, A. M.

AU - O'Mahony, S.

AU - Kubera, M.

AU - Kim, Yong Ku

AU - Kenny, C.

AU - Kaim-Basta, A.

AU - Steinbusch, H. W.M.

AU - Leonard, B. E.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Treatment with pro-inflammatory cytokine, IFNα was documented to result in neuropsychiatric complications including depression and treatment with antidepressant, paroxetine could improve the depressive symptoms. Therefore, the effects of IFNα on behaviour and cytokine changes in the whole blood culture and in the prefrontal cortex, hypothalamus and hippocampus areas of the brain in wistar rats were investigated with emphasis on the role of paroxetine in the prevention of depressive behaviour induced by pro-inflammatory cytokines. The group of rats treated with IFNα (S.C. 50 000 IU/kg for 3 days/week for 5 weeks) was compared with three other groups; 1) saline control group (S.C. normal saline 0.2 ml/kg/day for 7 weeks), 2) paroxetine control group (paroxetine suspension orally 10 mg/kg/day for 7 weeks) and 3) group treated with paroxetine for 2 weeks followed by IFNα for 5 weeks. In open filed, the IFNα treated rats showed anxiety behaviour compared to the rats from the other groups. There was no significant difference in home cage emergence test, Morris water maze and object recognition test. There is no significant difference in plasma corticosterone between groups. The pro-inflammatory cytokines (TNFα, IL1β and IFNγ), were significantly higher whereas the anti-inflammatory cytokine, IL10 was lower in the stimulated whole blood culture of IFNα treated rats. In the brain, both pro-inflammatory cytokine IL1β and anti-inflammatory cytokine IL10 were higher in hypothalamus of the IFNα treated rats; by contrast the concentration of IL10 was lowest in hippocampus region of this group compared to the other groups. The paroxetine pretreated rats did not show these cytokine changes following IFNα treatment. Thus it appears that paroxetine pretreatment prevents the pro-inflammatory changes in blood and brain following IFNα treatment in turn prevents the anxiety behaviour.

AB - Treatment with pro-inflammatory cytokine, IFNα was documented to result in neuropsychiatric complications including depression and treatment with antidepressant, paroxetine could improve the depressive symptoms. Therefore, the effects of IFNα on behaviour and cytokine changes in the whole blood culture and in the prefrontal cortex, hypothalamus and hippocampus areas of the brain in wistar rats were investigated with emphasis on the role of paroxetine in the prevention of depressive behaviour induced by pro-inflammatory cytokines. The group of rats treated with IFNα (S.C. 50 000 IU/kg for 3 days/week for 5 weeks) was compared with three other groups; 1) saline control group (S.C. normal saline 0.2 ml/kg/day for 7 weeks), 2) paroxetine control group (paroxetine suspension orally 10 mg/kg/day for 7 weeks) and 3) group treated with paroxetine for 2 weeks followed by IFNα for 5 weeks. In open filed, the IFNα treated rats showed anxiety behaviour compared to the rats from the other groups. There was no significant difference in home cage emergence test, Morris water maze and object recognition test. There is no significant difference in plasma corticosterone between groups. The pro-inflammatory cytokines (TNFα, IL1β and IFNγ), were significantly higher whereas the anti-inflammatory cytokine, IL10 was lower in the stimulated whole blood culture of IFNα treated rats. In the brain, both pro-inflammatory cytokine IL1β and anti-inflammatory cytokine IL10 were higher in hypothalamus of the IFNα treated rats; by contrast the concentration of IL10 was lowest in hippocampus region of this group compared to the other groups. The paroxetine pretreated rats did not show these cytokine changes following IFNα treatment. Thus it appears that paroxetine pretreatment prevents the pro-inflammatory changes in blood and brain following IFNα treatment in turn prevents the anxiety behaviour.

KW - Anxiety

KW - Depression

KW - IL-10

KW - Interferon-α

KW - Proinflammatory cytokine

UR - http://www.scopus.com/inward/record.url?scp=35649019844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35649019844&partnerID=8YFLogxK

U2 - 10.1177/0269881107077165

DO - 10.1177/0269881107077165

M3 - Article

C2 - 17984161

AN - SCOPUS:35649019844

VL - 21

SP - 843

EP - 850

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

IS - 8

ER -